These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26279755)

  • 1. Different localization and expression of protein kinase C-beta in kidney cortex of diabetic nephropathy mice and its role in telmisartan treatment.
    Wang J; Qin F; Deng A; Yao L
    Am J Transl Res; 2015; 7(6):1116-25. PubMed ID: 26279755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protein kinase C-betaI, betaII in mouse diabetic nephropathy kidney and its relation to nephroprotective actions of the angiotensin receptor blocker telmisartan].
    Yao LJ; Wang JQ; Deng AG; Liu JS
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1991-5. PubMed ID: 17923043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of telmisartan on expression of protein kinase C-alpha in kidneys of diabetic mice.
    Yao LJ; Wang JQ; Zhao H; Liu JS; Deng AG
    Acta Pharmacol Sin; 2007 Jun; 28(6):829-38. PubMed ID: 17506942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different expressions of protein kinase C-alpha, beta I and beta II in glomeruli of diabetic nephropathy patients.
    Yao L; Wang J; Mao Y; Zhu H; Deng A; Zhu Z
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):651-3. PubMed ID: 17357479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice.
    Sato-Horiguchi C; Ogawa D; Wada J; Tachibana H; Kodera R; Eguchi J; Nakatsuka A; Terami N; Shikata K; Makino H
    Nephron Exp Nephrol; 2012; 121(3-4):e97-e108. PubMed ID: 23307263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy.
    Toyoda M; Suzuki D; Honma M; Uehara G; Sakai T; Umezono T; Sakai H
    Kidney Int; 2004 Sep; 66(3):1107-14. PubMed ID: 15327405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 in diabetic nephropathy.
    Metwally SS; Mosaad YM; Nassr AA; Zaki OM
    Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Rao RP; Jain A; Srinivasan B
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):169-75. PubMed ID: 21421651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Koga K; Yamagishi S; Takeuchi M; Inagaki Y; Amano S; Okamoto T; Saga T; Makita Z; Yoshizuka M
    Mol Med; 2002 Oct; 8(10):591-9. PubMed ID: 12477969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.